https://www.utidebio.com/news-media/what-to-know-about-zepbound-tirzepatide-the-new-mounjaro-like-weight-loss-drug/2025-08-14T09:58:19+08:00https://www.utidebio.com/news-media/how-estrogen-affects-osteoporosis-and-bone-health/2025-08-13T18:51:38+08:00https://www.utidebio.com/news-media/weight-loss-drug-semaglutide-may-reduce-alcohol-cravings-heavy-drinking-and-smoking-new-study-finds/2025-08-14T17:56:43+08:00https://www.utidebio.com/news-media/physiology-of-glp-1-and-its-role-in-the-pathophysiology-of-type-2-diabetes/2025-08-14T17:54:12+08:00https://www.utidebio.com/news-media/glp-1-medicines-and-what-they-are-used-for/2025-08-14T17:56:14+08:00https://www.utidebio.com/news-media/targeting-glp-1-in-the-brain-could-transform-obesity-treatment/2025-08-14T17:53:37+08:00https://www.utidebio.com/news-media/concerns-with-semaglutide-and-other-glp-1-receptor-agonists/2025-08-14T18:02:40+08:00https://www.utidebio.com/news-media/semaglutide-double-edged-sword-with-risks-and-benefits/2025-08-26T11:40:12+08:00https://www.utidebio.com/news-media/advancements-in-peptide-synthesis-technologies/2025-08-14T09:58:34+08:00https://www.utidebio.com/news-media/semaglutide-cuts-risk-of-major-cardiovascular-events-in-type-2-diabetes-sustain-6/2025-08-14T09:58:52+08:00https://www.utidebio.com/news-media/injectable-glp-1-agonist-semaglutide-gets-cvd-event-reduction-indication/2025-08-14T09:59:13+08:00https://www.utidebio.com/news-media/the-global-market-landscape-for-peptide-drug-conjugates/2025-08-14T09:59:27+08:00https://www.utidebio.com/news-media/could-diversity-in-clinical-trials-be-the-key-to-understanding-liver-disease/2025-08-14T09:59:39+08:00https://www.utidebio.com/news-media/semaglutide-helps-reduce-risk-of-heart-attack-stroke-in-people-without-diabetes-study-finds/2025-08-14T09:59:49+08:00https://www.utidebio.com/news-media/semaglutide-a-new-pathway-to-cvd-risk-reduction-select/2025-08-14T10:00:03+08:00https://www.utidebio.com/news-media/semaglutide-reduces-cardiovascular-events-by-20-in-overweight-or-obese-adults-who-dont-have-diabetes-trial/2025-08-14T09:55:03+08:00